eXegenics Inc (United States)

OPK NAS
Pharmaceuticals
Miami, FL
2016 Revenue (US$ Millions)$1,222
Revenue Growth (%)148.44%
2015 Revenue (US$ Millions)$492
Net Income (US$ Millions)($25)
Common Shares Outstanding (Millions)557.99
Earnings Per Share (US$)($0.05)
Price to Earnings RatioN/A
Total Equity (US$ Millions)$2,092
Return on Equity (%)-1.27%
Long Term Debt (US$ Millions)$90
Debt to Equity Ratio (%)0.04%
Market Capitalization (US$ Millions)$5,189
Total Assets (US$ Millions)$2,767
Current Assets (US$ Millions)$484
Inventories (US$ Millions)$47
Current Liabilities (US$ Millions)$263
Cost Of Goods Sold (US$ Millions)$611
Asset Turnover0.44
Inventory Turnover14.07